C12N 2770/32021
Viruses as such
Official title: Viruses as such, e.g. new isolates, mutants or their genomic sequences
C12N2770/32021 (Viruses as such) appears on 18 US grants and 35 published applications in this corpus.
Search patents in C12N- Granted patents
- 18
- Published applications
- 35
- Assignees
- 29
- Inventors
- 115
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2005 | 0 | 1 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 1 | 0 |
| 2010 | 0 | 1 |
| 2011 | 2 | 0 |
| 2012 | 0 | 2 |
| 2013 | 0 | 1 |
| 2014 | 1 | 2 |
| 2015 | 1 | 3 |
| 2016 | 1 | 3 |
| 2017 | 2 | 2 |
| 2018 | 2 | 1 |
| 2019 | 1 | 0 |
| 2020 | 0 | 5 |
| 2021 | 2 | 1 |
| 2022 | 1 | 4 |
| 2023 | 0 | 0 |
| 2024 | 1 | 2 |
| 2025 | 1 | 3 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Senecavirus A virus strains and immunogenic compositions therefrom6 Jan 2026US 12,514,917 B2South Dakota Board of Regents
- Oncolytic virus expressing a car T cell target and uses thereof22 Jul 2025US 12,364,724 B2City of Hope
- Recombinant nucleic acid of Seneca valley virus, recombinant vaccine strain and preparation method and use thereof30 Jan 2024US 11,883,482 B2Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences
- Stable production of virulent enterovirus 71 and use thereof24 May 2022US 11,339,376 B2Tokyo Metropolitan Institute of Medical Science
- Senecavirus a immunogenic compositions and methods thereof23 Nov 2021US 11,179,457 B2
- Intracellular Delivery of Therapeutic Cargos and Viral RNAS by Engineered Salmonella17 Sep 2026US 2026/0272995 A1The Trustees of Columbia University in the City of New York
- Oncolytic Viruses as Therapeutic Agents for Treating Cancer6 Aug 2026US 2026/0226426 A1ImmVirX Pty Ltd
- Oncolytic virus expressing a car t cell target and uses thereof18 Dec 2025US 2025/0381237 A1City of Hope
- Production of rna polynucleotides encoding picornavirus11 Sep 2025US 2025/0281556 A1ElevateBio Technologies, Inc.
- Coxsackievirus b4 strain and application thereof9 Jan 2025US 2025/0009867 A1Institute of Medical Biology, Chinese Academy of Medical Sciences
Most cited
By later US patents
- Nylanderia pubens virus19US 9,591,858 B2The United States of America as represented by the Secretary of Agriculture · 2017
- Viruses associated with immunodeficiency and enteropathy and methods using same9US 9,683,268 B2Beth Israel Deaconess · 2017
- Seneca Valley virus based compositions and methods for treating disease5US 7,638,318 B2Norvartis AG · 2009
- Seneca Valley virus based compositions and methods for treating disease4US 8,039,606 B2Novartis AG · 2011
- Seneca valley virus based compositions and methods for treating disease3US 8,753,622 B2Novartis AG · 2014